Robinhood board approves strategy to obtain again Sam Bankman-Fried’s $578 million stake

Robinhood board approves strategy to obtain again Sam Bankman-Fried’s 8 million stake


Rafael Henrique | Sopa Illustrations or photos | Lightrocket | Getty Visuals

The board of directors of Robinhood has authorized a system to get up to 55 million shares purchased by Sam Bankman-Fried final 12 months. The ex-CEO of the now bankrupt crypto exchange FTX at first obtained his stake in May 2022 by way of Emergent Fidelity Systems.

The retail brokerage is operating with the Division of Justice, which seized the shares in January, to facilitate the go.

Shares of Robinhood are up additional than 3% in after-hrs trading subsequent the launch of its quarterly earnings report that confirmed web income increasing 5% from last quarter to $380 million.

“Our board approved us to acquire the shares of Robinhood that had been initially acquired by Emergent Fidelity Systems, that FTX subsidiary,” Robinhood Chief Monetary Officer Jason Warnick advised CNBC.

“And which is been a major concern on shareholders’ minds, and a technical overhang, what is likely to take place with these shares,” Warnick mentioned.

“The board has authorized us to go and repurchase these and so we are in conversations with the DOJ on that. Challenging to tell accurately what the timeline is heading to be,” Warnick additional.

“Since there is minimal precedent for this variety of situation, we can’t forecast when, or if, the share acquire will get spot. We will give updates as appropriate,” the business said in its earnings report launch.

In accordance to a Jan. 20 filing by the DOJ, Bankman-Fried held 55,273,469 Robinhood shares, around 7% of the firm’s fantastic shares. As of Wednesday’s near, that stake is valued at around $578 million.

Emergent Fidelity was controlled by both Bankman-Fried and fellow FTX co-founder Gary Wang. Both of those Wang and Bankman-Fried took out loans straight from Alameda Research to fund the acquisition, in accordance to court filings. The shares are also at the heart of a contentious courtroom struggle involving FTX, Bankman-Fried, crypto financial institution BlockFi and a established of worldwide entities.

CNBC’s Kate Rooney contributed to this report.



Supply

Google joins Microsoft in telling users Anthropic is still available outside defense projects
World

Google joins Microsoft in telling users Anthropic is still available outside defense projects

Google CEO Sundar Pichai gestures to the crowd during Google’s annual I/O developers conference in Mountain View, California, on May 20, 2025. David Paul Morris | Bloomberg | Getty Images Google said it will continue offering Anthropic’s artificial intelligence technology for clients, excluding for defense work, a day after Microsoft issued a similar statement to […]

Read More
Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide
World

Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide

The U.S. and Israel are showing signs of escalating their war against Iran – a move that could batter a variety of assets, even traditional safe havens. To protect their portfolios, investors can snap up stocks from an oft-shorted sector: pharmaceuticals, UBS analysts say. Since the first strikes last Saturday, the Iran War has roiled […]

Read More
Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’
World

Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’

Wegovy is produced by pharmaceutical company Novo Nordisk and has been approved for specifically for chronic weight management in adults and adolescents. (Photo by Steve Christo – Corbis/Corbis via Getty Images) Steve Christo – Corbis | Corbis News | Getty Images The chief executive of drugmaker Zealand Pharma sought to calm investors about the latest […]

Read More